OverviewSuggest Edit

Glucose Health, Inc. offers a dietary supplement targeted to the large and growing market of proactive consumers interested in healthy blood sugar, triglycerides and cholesterol and regular digestive health. The product utilizes a formula consisting of nine 9 essential ingredients, including extracts of green and white teas, extracts of cinnamon tree bark, chromium GTF (Glucose Tolerance Factor) and soluble dietary fiber.

TypePublic
Founded2014
HQBentonville, US
Websiteglucosehealthinc.com

Latest Updates

Employees (est.) (Sept 2017)2
Revenue (FY, 2016)$313.2 K(+7233%)
Share Price (Nov 2020)$2.7 (+17%)
Cybersecurity ratingBMore

Key People/Management at Glucose Health

Murray Fleming

Murray Fleming

CEO, CFO
Hal Kravitz

Hal Kravitz

Director
John Fieldly

John Fieldly

Director
Gerry David

Gerry David

Director
Show more

Glucose Health Office Locations

Glucose Health has an office in Bentonville
Bentonville, US (HQ)
609 SW 8th St
Show all (1)

Glucose Health Financials and Metrics

Glucose Health Revenue

Glucose Health's revenue was reported to be $313.23 k in FY, 2016
USD

Revenue (Q3, 2017)

23.8k

Gross profit (Q3, 2017)

23.0k

Gross profit margin (Q3, 2017), %

96.7%

Net income (Q3, 2017)

18.8k

EBIT (Q3, 2017)

4.6k

Market capitalization (17-Nov-2020)

751.9k

Closing stock price (17-Nov-2020)

2.7

Cash (30-Sept-2017)

16.6k

EV

755.3k
Glucose Health's current market capitalization is $751.9 k.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

(224.0)2.7k4.3k313.2k

Cost of goods sold

2.3k23.5k3.9k294.1k

Gross profit

(2.5k)(20.7k)397.019.2k

Gross profit Margin, %

1133%(757%)9%6%
Quarterly
USDQ3, 2011Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

224.047.0442.02.3k25.0552.02.1k120.0295.8k2.1k15.1k34.0k23.8k

Cost of goods sold

874.013.1k1.0k9.3k2.1k340.02.0k60.0274.5k4.7k14.6k272.0790.0

Gross profit

(12.9k)(953.0)(8.8k)133.0212.0105.060.021.3k(2.6k)473.033.8k23.0k

Gross profit Margin, %

(5737%)(2028%)(2000%)6%38%5%50%7%(124%)3%99%97%
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

82.01.1k711.04.9k2.1k20.5k

Accounts Receivable

3.2k11.7k

Prepaid Expenses

27.0k38.9k1.3k639.0

Inventories

24.9k8.4k
Quarterly
USDQ3, 2011Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

3.9k220.0277.02.8k16.5k269.0472.0879.03.0k4.2k8.8k1.9k27.8k23.6k9.0k18.3k16.6k

Accounts Receivable

2.0k3.2k168.3k11.7k9.6k8.8k9.1k

Prepaid Expenses

27.0k27.0k40.7k5.0k467.021.5k4.1k37.7k2.1k1.6k417.0

Inventories

83.3k43.9k27.9k23.7k15.1k12.9k12.5k11.7k9.7k8.3k8.3k6.4k
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(899.2k)(399.1k)(1.5m)(669.4k)(266.1k)(410.4k)

Depreciation and Amortization

60.0

Inventories

(24.9k)10.5k(8.4k)(8.4k)

Accounts Payable

89.6k21.9k32.4k21.8k(59.7k)
Quarterly
USDQ3, 2011Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(729.6k)(192.3k)(475.3k)(235.7k)(580.3k)(726.9k)(46.4k)(148.9k)(253.3k)(120.0k)(170.0k)(219.3k)(29.3k)(125.5k)(286.4k)(29.0k)20.2k39.0k

Depreciation and Amortization

15.030.045.0

Inventories

(43.9k)(27.9k)1.2k1.8k4.1k(12.5k)(11.6k)(9.7k)60.060.02.0k

Accounts Payable

103.5k(3.7k)4.0k23.3k(2.1k)9.5k21.5k15.2k11.9k387.0(17.4k)(17.6k)10.1k85.6k53.6k14.7k1.3k(58.1k)
USDQ3, 2011

Financial Leverage

-1 x
Show all financial metrics

Glucose Health Cybersecurity Score

Cybersecurity ratingPremium dataset

B

85/100

SecurityScorecard logo

Glucose Health Online and Social Media Presence

Embed Graph

Glucose Health News and Updates

Glucose Health, Inc. Fiscal 2020 3rd Quarter Revenue Increases 91% Beating Preliminary Estimate By 11%

BENTONVILLE, Ark., Nov. 9, 2020 /PRNewswire/ -- Glucose Health, Inc. (OTC: GLUC) revenue for the quarterly period ending September 30, 2020 increased 91% vs. the comparative 2019 period. Previously, on October 1, 2020, a preliminary sales tally at the close of the third quarter suggested...

Glucose Health, Inc. 3Rd Quarter 2020 Preliminary Results Indicate 80% Revenue Increase

BENTONVILLE, Ark., Oct. 1, 2020 /PRNewswire/ -- Glucose Health, Inc. (OTC: GLUC) today advised that preliminary sales figures indicate an 80% revenue increase for the 3rd quarter ending September 30, 2020, vs the prior quarterly period, ending September 30, 2019. This better-than-expected...

Glucose Health, Inc. Reports Unprecedented Consumer Demand and 2nd Quarter Fiscal 2020 Revenues

BENTONVILLE, Ark., Aug. 12, 2020 /PRNewswire/ -- Glucose Health, Inc. (OTC: GLUC) – the manufacturer of GLUCODOWN® – today reported 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – Q2 2020 revenues were just $7,140 short of tripling 2nd quarter...

Glucose Health, Inc. Amazon Sales for June Increase 1,284% YOY

BENTONVILLE, Arkansas, July 8, 2020 /PRNewswire/ -- Glucose Health, Inc. (OTC: GLUC) – the manufacturer of GLUCODOWN® – today advised that June 2020 sales at Amazon were $38,594.89 vs. June 2019 sales of $2,787.87 – a 1,284% increase demonstrating the tremendous growth the GLUCODOWN®...

Amazon Sales Increase 1048% as New GLUCODOWN® by Glucose Health, Inc. TV Campaign to Launch on CNBC, BLOOMBERG & FOX BUSINESS

BENTONVILLE, Arkansas, June 17, 2020 /PRNewswire/ -- Glucose Health, Inc. (OTC: GLUC) – the manufacturer of GLUCODOWN® – today advised that May 2020 sales of GLUCODOWN® at Amazon were $33,185.40 vs. May 2019 sales of $2,889.71 – a 1048% increase. Additionally, May 2020 sales of GLUCODOWN®...

John Fieldly Appointed to Board of Directors of Glucose Health, Inc.

BENTONVILLE, Ark., June 10, 2020 /PRNewswire/ -- Glucose Health, Inc. (OTC: GLUC) is pleased to announce that Mr. John Fieldly has accepted an invitation to join the company's Board of Directors. Mr. Fieldly is the President and Chief Executive Officer of Celsius Holdings, Inc. (NASDAQ:...
Show more

Glucose Health Frequently Asked Questions

  • When was Glucose Health founded?

    Glucose Health was founded in 2014.

  • Who are Glucose Health key executives?

    Glucose Health's key executives are Murray Fleming, Hal Kravitz and John Fieldly.

  • How many employees does Glucose Health have?

    Glucose Health has 2 employees.

  • What is Glucose Health revenue?

    Latest Glucose Health annual revenue is $313.2 k.

  • What is Glucose Health revenue per employee?

    Latest Glucose Health revenue per employee is $156.6 k.

  • Who are Glucose Health competitors?

    Competitors of Glucose Health include Global Healing Center, Swerve Sweetener and Oviva.

  • Where is Glucose Health headquarters?

    Glucose Health headquarters is located at 609 SW 8th St, Bentonville.

  • Where are Glucose Health offices?

    Glucose Health has an office in Bentonville.

  • How many offices does Glucose Health have?

    Glucose Health has 1 office.